Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18370574 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia
Condition: Schizophrenia
Interventions: Drug: aripiprazole;   Drug: placebo

Indicates status has not been verified in more than two years